Pasar al contenido principal

Main navigation

    • About us
    • Our work
    • Rationale
    • IDDO Team
    • Contact us
    • Our partners
    • Governance
    • IDDO Board
    • Data Access Committee
    • Data reuse
    • Contributing data
    • Accessing data
    • IDDO legal and regulatory documentation
    • IDDO data sharing registrations
    • Data Access Guidelines
    • Frequently Asked Questions
    • Research themes
    • WWARN - malaria
    • COVID-19
    • Ebola
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
    • Research
    • Malaria Tracking Resistance
    • Malaria Clinical Trials Toolkit
    • COVID-19 LSR Tool
    • VL Tool
    • Medicine Quality Monitoring Globe
    • Medicine Quality Scientific Literature Surveyor
    • Febrile Illness Surveyor
    • Publications
    • Tools & resources
    • Medical Product Quality Reports
  • News

User account menu

  • Iniciar sesión
  • Register
  • Contact
BandwidthAlto

Language switcher

  • English
  • Français
  • Español
    • Overview
    • AMR Team
    • About GRAM
    • Work with GRAM
    • Accessing data
    • Contributing data
    • Publications
  • News
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

News

BMC Medicine
i
BMC Medicine
News Article
03 Abr 2019
Research highlight: New guidelines for reporting microbiology data
The economic costs of antimicrobial resistance (AMR) are higher than the sales price of most popular antibiotics, according to a recent MORU/IDDO study. Curbing the unnecessary use of antibiotics is key to dealing with the AMR issue head on, particularly in SE Asia, which has the highest rates of AMR and a big, informal medicine dispensing sector that aggravates the AMR problem. ©2018 MORU/Wellcome.
i
The economic costs of antimicrobial resistance (AMR) are higher than the sales price of most popular antibiotics, according to a recent MORU/IDDO study. Curbing the unnecessary use of antibiotics is key to dealing with the AMR issue head on, particularly in SE Asia, which has the highest rates of AMR and a big, informal medicine dispensing sector that aggravates the AMR problem. ©2018 MORU/Wellcome.
News Article
22 Ago 2018
Study details high hidden economic costs of antibiotic consumption
IDDO/ Mehul Dhorda
i
Credit: IDDO/ Mehul Dhorda
News Article
05 Mar 2018
Study analyses AMR networks in low- and middle-income countries

Paginación

  • Primera página « First
  • Página anterior ‹ Previous
  • Página 1
  • Página actual 2

Sign up for the IDDO newsletter

Sign up for the WWARN newsletter
linkedin [#161] Created with Sketch. youtube

Footer menu

  • Cookies
  • Privacy Notice
  • Accessibility
  • Sitemap
  • Terms of use
© 2025 Infectious Diseases Data Observatory